The government has recognized and accepted the industry's critical demand for PTUAS (Pharmaceutical Technology Upgradation Assistance Scheme) changes to better support improving quality standards, said Arunish Chawla.
A recent event on AI in Healthcare saw the introduction of a new theme, AI-driven innovation in Healthcare, expanding the discourse well beyond the technology’s role in EMR (electronic medical record) adoption, physician productivity.
Nethradhama Super Specialty Eye Hospitals performed the first refractive cataract surgery in India using Femtis Mplus. The latest innovation in ophthalmology is the paradigm-changing cataract surgery that combines defect correction.
As International Women's Day approaches, Clinics on Cloud, India's leading health tech company, unveils transformative insights into women's health, shedding light on the profound impact of accessible healthcare solutions.
Luye Pharma has launched Zepzelca (lurbinectedin), a new drug for treating SCLC in Hong Kong and Macau.
Shares of Sun Pharmaceutical Industries rose about 2%, hitting a 52-week high late on March 6, after the U.S. Food and Drug Administration (FDA) said it had granted full approval to Active Pharmaceutical Ingredient (API) from Ankleshwar Company).
The Indian healthcare innovation market is anticipated to reach an estimated $60 billion by FY 2028, with Indian companies increasingly leveraging emerging technologies to add innovation vectors, including new business models
Ayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned, independently operated subsidiary of Bayer AG, announced details of 18-month data from the phase I clinical trial for bemdaneprocel
The Delhi High Court has asked the Union Ministry of Health and Family Welfare to frame a policy of online sale of drugs within four months and warned that this would be the last and final opportunity for the Ministry for the same.
Venus Remedies Ltd has received its first disbursement of Rs 7.5 crore under the Central government's Production Linked Incentive (PLI) scheme for the fiscal year 2022-23, which accounts for 75% of the total incentive due to the company for the ye...
, CDSCO.jpg)
